Introduction: Who Should Seek Diagnostics

Chronic lymphocytic leukemia is unique among cancers because it can be present in the body for months or even years before causing any noticeable problems. In fact, most people learn they have this condition not because they felt sick, but because routine blood work during a regular physical examination revealed unusually high numbers of white blood cells called lymphocytes, which are a type of cell that normally helps fight infections.^[1][2]

Anyone experiencing certain warning signs should consider seeking medical evaluation. These signs include swollen lymph nodes in the neck, underarms, or groin that don’t hurt but don’t go away. Other symptoms that warrant a doctor’s visit include unusual tiredness that doesn’t improve with rest, frequent infections that seem to happen more often than they used to, unexplained weight loss without trying to lose weight, fever without an obvious cause, drenching night sweats that soak through clothing or sheets, and easy bruising or bleeding.^[1][6]

People with a family history of chronic lymphocytic leukemia or other blood and bone marrow cancers should be particularly attentive to these symptoms, as having close relatives with the condition increases risk two to four times. White individuals over age 50, especially men, are more likely to develop this type of leukemia.^[2][4]

Classic Diagnostic Methods

The journey to diagnosing chronic lymphocytic leukemia typically begins with a thorough physical examination and a detailed discussion about your medical history and any symptoms you may be experiencing. During the physical exam, your healthcare provider will carefully check for swollen lymph nodes by feeling the areas in your neck, underarms, and groin. They will also examine your abdomen to see if your spleen or liver feels enlarged, which happens when cancerous white blood cells accumulate in these organs.^[12]

Blood Tests: The Foundation of Diagnosis

Blood tests form the core of diagnosing chronic lymphocytic leukemia. The most fundamental test is the complete blood count, which measures the number of different types of cells in your blood. In chronic lymphocytic leukemia, this test typically reveals an elevated number of lymphocytes—usually greater than or equal to 5,000 cells per cubic millimeter of blood. The complete blood count also checks levels of red blood cells, which carry oxygen throughout your body, and platelets, which help your blood clot to stop bleeding.^[6][15]

Another blood test called a peripheral blood smear allows laboratory professionals to examine what your blood cells actually look like under a microscope. In chronic lymphocytic leukemia, the smear often shows many small, round lymphocytes. Sometimes these cells appear smudged or broken on the slide, which is actually a characteristic feature that helps confirm the diagnosis. These are called “smudge cells” and occur because the leukemia cells are more fragile than normal lymphocytes.^[12]

Flow Cytometry: Identifying the Specific Cell Type

Flow cytometry is a specialized laboratory technique that identifies proteins on the surface of cells. Every type of cell in your body has unique protein markers that act like identification badges. In chronic lymphocytic leukemia, the cancerous B cells carry specific markers called CD5 and CD23, which normal B cells do not typically have together. This test is essential because it distinguishes chronic lymphocytic leukemia from other types of blood cancers and confirms the diagnosis.^[6][15]

Genetic and Molecular Testing

Once the basic diagnosis is confirmed, additional tests examine the genetic makeup of the leukemia cells. Fluorescence in situ hybridization, often abbreviated as FISH, looks for specific changes in the chromosomes inside the cancer cells. This test searches for missing pieces of chromosomes, which are called deletions, as well as extra copies of chromosomes or pieces that have moved to the wrong place. The specific genetic changes detected can help predict how the disease might behave and guide treatment decisions.^[15]

Another important genetic test looks for mutations, or changes, in a gene called TP53. This gene normally helps control cell growth, and when it’s damaged, the leukemia may be more aggressive or may not respond as well to certain treatments. Blood tests can also measure levels of proteins in your blood, such as lactate dehydrogenase and beta-2-microglobulin, which can provide additional information about disease activity.^[15]

Bone Marrow Examination

In some cases, doctors may recommend a bone marrow biopsy and aspiration. This procedure involves using a thin, hollow needle to collect a small sample of bone marrow, usually from the hip bone. The bone marrow is the spongy tissue inside bones where blood cells are made. Examining this sample under a microscope shows how many leukemia cells are present in the marrow and how they affect production of normal blood cells. However, this test is not always necessary for diagnosis, especially if blood tests already provide clear answers. It may be recommended if blood counts are unusually low and the reason isn’t clear.^[4][12]

Imaging Studies

Imaging tests are not typically required for everyone with chronic lymphocytic leukemia, but they may be ordered in certain situations. A computed tomography scan, or CT scan, creates detailed cross-sectional images of the inside of your body. This test might be performed if you have enlarged lymph nodes that can be felt during examination, to check whether lymph nodes deeper inside the body, such as those in the abdomen or chest, are also affected. Imaging helps doctors understand the extent of the disease but is usually not needed if there are no enlarged nodes felt during the physical exam.^[15]

Additional Laboratory Tests

Several other blood tests help build a complete picture of your health and the disease. Tests for liver and kidney function check how well these organs are working, which is important for planning treatment. Testing the levels of different types of antibodies in your blood, called immunoglobulins, shows whether your immune system is functioning properly, since chronic lymphocytic leukemia often causes these levels to drop. Some people with this condition develop immune-related complications, such as Coombs-positive hemolytic anemia, where the immune system mistakenly destroys red blood cells. Tests like the direct Coombs test can detect this problem.^[15]

Because people with chronic lymphocytic leukemia have weakened immune systems, screening for infections like hepatitis B, hepatitis C, and HIV is also standard practice. This information helps doctors take precautions and provide appropriate care if any of these infections are present.^[15]

Diagnostics for Clinical Trial Qualification

When considering participation in clinical trials, patients with chronic lymphocytic leukemia undergo additional testing beyond the standard diagnostic workup. Clinical trials are research studies that test new treatments or combinations of treatments, and they require specific information to determine whether a patient is eligible and to ensure their safety during the study.^[16]

Standardized Blood and Marrow Assessments

Clinical trials typically require a complete set of baseline blood tests performed shortly before enrollment. These include a detailed complete blood count with differential, which breaks down the exact proportions of different white blood cell types. Chemistry panels that measure kidney function through creatinine levels, liver function through transaminase and bilirubin levels, and overall metabolic health are standard requirements. Trials often measure additional markers like lactate dehydrogenase and beta-2-microglobulin, which provide information about disease burden and prognosis.^[15]

Some clinical trials require a bone marrow biopsy and aspiration before enrollment, even if this wasn’t done during initial diagnosis. This provides researchers with detailed information about how the leukemia affects the bone marrow and establishes a baseline for measuring treatment response.^[15]

Genetic and Molecular Characterization

Clinical trials frequently require comprehensive genetic testing that goes beyond routine clinical care. FISH testing for specific chromosomal abnormalities, including deletions of chromosomes 11q, 13q, and 17p, as well as trisomy 12 (an extra copy of chromosome 12), is usually mandatory. Testing for TP53 gene mutations is critical for many trials, as some treatments are specifically designed for patients with or without this mutation.^[15]

Another important test examines the immunoglobulin heavy-chain variable region gene, abbreviated as IGHV. This gene can be either mutated or unmutated in chronic lymphocytic leukemia cells. The mutation status helps predict how aggressive the disease might be and influences treatment selection in clinical trials. Patients with unmutated IGHV typically have more aggressive disease, while those with mutated IGHV often have slower-progressing leukemia.^[7]

Immunophenotyping by Flow Cytometry

Clinical trials require detailed immunophenotyping, which means identifying and counting the specific markers on the surface of leukemia cells. This goes beyond the basic CD5 and CD23 testing used for diagnosis. Trials often measure additional markers to characterize the exact subtype of leukemia cells and track how they respond to treatment. The test identifies whether the cells are B cells or, in rare cases, T cells, and provides information about the maturity and characteristics of these cells.^[15]

Imaging Requirements

Many clinical trials mandate baseline imaging studies, usually CT scans of the chest, abdomen, and pelvis. These scans create a detailed map of all affected lymph nodes and organs before treatment begins. Researchers use this baseline information to measure whether the treatment is working by comparing follow-up scans taken during and after the trial. The scans measure lymph nodes in multiple dimensions and track changes in the size of the spleen and liver if they are enlarged.^[15]

Performance Status and Overall Health Assessment

Clinical trials assess not just the leukemia itself but also the patient’s overall health and ability to function in daily life. This includes recording vital signs like blood pressure, heart rate, breathing rate, and temperature. Some trials require specific heart tests, such as an electrocardiogram, to ensure the heart is healthy enough for the investigational treatment. Others may require testing for specific infections or confirming vaccination status.^[6]

Documenting the exact size of palpable lymph nodes—those that can be felt during examination—in the cervical (neck), axillary (underarm), and inguinal (groin) areas is standard for clinical trials. This physical measurement provides an additional way to track treatment response alongside blood tests and imaging.^[15]